Arich Enterprise Co (4173) Fair Value & Analysis
Healthcare · TW · Market cap 1.4B TWD
Fair value as of: Jun 24, 2026
Analysis
Arich Enterprise Co (4173) currently trades at 18.00 TWD, while our model-based Fair Value estimate is 24.44 TWD — implying the stock looks roughly 35.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion for pharmaceutical products; warehousing and logistics, and processing services. The company provides distribution and logistics services, including assists manufacturers with bidding processes; inventory management, order processing, invoicing, goods delivery, collection, customer complaint handling, and provides integrated pharmaceutical distribution services. In addition, it offers activities, such as hospital tender and bidding; pharmaceutical pricing negotiations; cold chain, clinical trial drug, and controlled drugs management; information, and financial flow. Arich Enterprise Co., Ltd. was founded in 1969 and is based in New Taipei City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Arich Enterprise Co (4173) undervalued?
What is the fair value of 4173?
What is the quality score of 4173?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.